WEBINAR: Navigating Industry Partnerships & Sponsored Research: A Practical Guide for Faculty
DATE: Tuesday, December 1, 2026
TIME: 3:00 PM – 4:00 PM PT
FREE
Description:
The Department of Medicine, in collaboration with the UCLA Metabolism Research Theme and the UCLA Technology Development Group (TDG), invite faculty to an interactive session focused on building productive industry partnerships and enhancing opportunities for investigator-initiated research collaborations.
During this session, presenters will provide practical guidance on initiating and cultivating corporate collaborations, alongside strategies for navigating Industry Sponsored Research (ISR) agreements, Material Transfer Agreements (MTAs), and non-dilutive funding. The discussion will also cover best practices for intellectual property strategy—protecting academic discoveries and positioning them for clinical translation—as well as an inside look at the industry perspective on what biopharma executives prioritize when partnering with academic investigators.
Presenters & Guest Speaker:
Mark Wisniewski, MS, MBA (Senior Director, Biopharmaceuticals, UCLA TDG)
Mark leads biopharmaceutical and life science intellectual property at UCLA, managing portfolio licensing, marketing, and inventor outreach. His background spans biotech management, entrepreneurship, and commercialization across startups and Fortune 100 organizations, including leadership roles at Prolacta Bioscience and Baxter Healthcare, as well as serving as a principal advisor for NIH and NCI commercialization accelerator programs. He earned his MBA from the UCLA Anderson School of Management and his Master’s in Immunology and Microbiology from the UCLA School of Medicine.
Karla Zepeda, MS (Senior Director, Research & Industry Alliances – Medicine, UCLA TDG)
Karla partners closely with faculty seeking to secure research funding from industry and non-profit sponsors, guiding them through Industry Sponsored Research and Material Transfer Agreements. She has been with UCLA TDG since 2008, prior to which she worked as a contract specialist at UT Southwestern Medical Center. She holds a Bachelor of Science in Biology and Chemistry from CSU Chico and a Master of Science in Biotechnology from UT Texas.
Guest Speaker:
Guy Rosenthal (President & CEO, Oryn Therapeutics)
Guy leads Oryn Therapeutics, a company developing nature-inspired macrocyclic peptide therapies for complex inflammatory and autoimmune diseases. His career includes leading corporate and business development at Laekna Therapeutics, directing corporate development and investments at UCLA TDG, and managing global R&D collaborations at Teva Pharmaceuticals, following early work on novel gene therapy platforms at VBL Therapeutics.
Presented by UCLA TDG in partnership with the UCLA Department of Medicine
